Insider · CIK 0001706847

Velleca Mark A.

CIK 0001706847 Name as filed on the most recent filing

Filed as Velleca Mark A. (22)

48 transaction lines · from 22 filings · filed 2017-12-20 to 2023-08-10 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

48 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2023-08-08 S, Open-market sale G1 Therapeutics, Inc.GTHX 2 lines 119,974, disposed Open Form 4 filing 0001562180-23-006271
2022-10-18 S, Open-market sale G1 Therapeutics, Inc.GTHX 175,490, disposed Open Form 4 filing 0001562180-22-007293
2022-09-20 S, Open-market sale G1 Therapeutics, Inc.GTHX 270,044, disposed Open Form 4 filing 0001562180-22-006791
2022-08-16 S, Open-market sale G1 Therapeutics, Inc.GTHX 1,010,904, disposed Open Form 4 filing 0001562180-22-006214
2021-07-15 S, Open-market sale G1 Therapeutics, Inc.GTHX 184,898, disposed Open Form 4 filing 0001562180-21-004949
2021-07-14 S, Open-market sale G1 Therapeutics, Inc.GTHX 190,824, disposed Open Form 4 filing 0001562180-21-004949
2021-07-13 S, Open-market sale G1 Therapeutics, Inc.GTHX 194,536, disposed Open Form 4 filing 0001562180-21-004949
2021-06-17 S, Open-market sale G1 Therapeutics, Inc.GTHX 217,728, disposed Open Form 4 filing 0001562180-21-004348
2021-06-16 S, Open-market sale G1 Therapeutics, Inc.GTHX 217,384, disposed Open Form 4 filing 0001562180-21-004348
2021-06-15 S, Open-market sale G1 Therapeutics, Inc.GTHX 223,909, disposed Open Form 4 filing 0001562180-21-004348
2021-05-13 S, Open-market sale G1 Therapeutics, Inc.GTHX 205,413, disposed Open Form 4 filing 0001562180-21-003460
2021-05-12 S, Open-market sale G1 Therapeutics, Inc.GTHX 200,691, disposed Open Form 4 filing 0001562180-21-003460
2021-05-11 S, Open-market sale G1 Therapeutics, Inc.GTHX 190,997, disposed Open Form 4 filing 0001562180-21-003460
2021-04-15 S, Open-market sale G1 Therapeutics, Inc.GTHX 249,631, disposed Open Form 4 filing 0001562180-21-002835
2021-04-14 S, Open-market sale G1 Therapeutics, Inc.GTHX 245,272, disposed Open Form 4 filing 0001562180-21-002835
2021-04-13 S, Open-market sale G1 Therapeutics, Inc.GTHX 238,865, disposed Open Form 4 filing 0001562180-21-002835
2021-02-18 S, Open-market sale G1 Therapeutics, Inc.GTHX 260,152, disposed Open Form 4 filing 0001562180-21-001280
2021-02-17 S, Open-market sale G1 Therapeutics, Inc.GTHX 2 lines 276,433, disposed Open Form 4 filing 0001562180-21-001280
2021-02-16 S, Open-market sale G1 Therapeutics, Inc.GTHX 3 lines 388,653, disposed Open Form 4 filing 0001562180-21-001280
2021-01-21 S, Open-market sale G1 Therapeutics, Inc.GTHX 206,400, disposed Open Form 4 filing 0001562180-21-000442
2021-01-20 S, Open-market sale G1 Therapeutics, Inc.GTHX 215,107, disposed Open Form 4 filing 0001562180-21-000442
2021-01-19 S, Open-market sale G1 Therapeutics, Inc.GTHX 208,781, disposed Open Form 4 filing 0001562180-21-000442
2020-12-17 S, Open-market sale G1 Therapeutics, Inc.GTHX 199,668, disposed Open Form 4 filing 0001562180-20-007341
2020-12-16 S, Open-market sale G1 Therapeutics, Inc.GTHX 192,021, disposed Open Form 4 filing 0001562180-20-007341
2020-12-15 S, Open-market sale G1 Therapeutics, Inc.GTHX 194,297, disposed Open Form 4 filing 0001562180-20-007341
2018-11-15 S, Open-market sale G1 Therapeutics, Inc.GTHX 2 lines 199,211, disposed Open Form 4 filing 0001562180-18-004596
2018-10-15 S, Open-market sale G1 Therapeutics, Inc.GTHX 2 lines 207,645, disposed Open Form 4 filing 0001562180-18-004218
2018-09-17 S, Open-market sale G1 Therapeutics, Inc.GTHX 3 lines 331,549, disposed Open Form 4 filing 0001562180-18-003988
2018-08-15 S, Open-market sale G1 Therapeutics, Inc.GTHX 2 lines 279,378, disposed Open Form 4 filing 0001562180-18-003666
2018-07-16 S, Open-market sale G1 Therapeutics, Inc.GTHX 2 lines 210,313, disposed Open Form 4 filing 0001562180-18-003317
2018-05-15 S, Open-market sale G1 Therapeutics, Inc.GTHX 2 lines 347,064, disposed Open Form 4 filing 0001562180-18-002515
2018-04-16 S, Open-market sale G1 Therapeutics, Inc.GTHX 2 lines 269,971, disposed Open Form 4 filing 0001562180-18-001897
2018-03-15 S, Open-market sale G1 Therapeutics, Inc.GTHX 286,466, disposed Open Form 4 filing 0001562180-18-001643
2018-02-15 S, Open-market sale G1 Therapeutics, Inc.GTHX 150,015, disposed Open Form 4 filing 0001562180-18-001026
2018-01-16 S, Open-market sale G1 Therapeutics, Inc.GTHX 172,395, disposed Open Form 4 filing 0001562180-18-000325
2017-12-18 S, Open-market sale G1 Therapeutics, Inc.GTHX 150,106, disposed Open Form 4 filing 0001562180-17-003961

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 48
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Velleca Mark A., insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001706847

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.